查詢結果分析
相關文獻
- Does Biofeedback Improve Symptoms of Schizophrenia (Emotion, Psychotic Symptoms, and Cognitive Function)?
- Dose-Response Relationships of Multisensory Intervention on Hospitalized Patients with Chronic Schizophrenia
- 電腦輔助認知方案對社區思覺失調症患者之復健成效
- 當事人使用生理回饋遊戲的情緒調適經驗之初探性研究--以三位當事人的經驗為例
- 思覺失調症之人臉情緒辨識及其與神經認知及心智推理之關係
- 重複透顱磁刺激術在思覺失調症病人認知功能障礙的臨床應用
- 園藝種植綠化方案對改善慢性思覺失調症患者自我污名感受之成效
- Excess Mortality, Risk of Acute Myocardial Infarction, and Related Medical Care Receipts in People with Serious Mental Illness
- Sex Differences Influence Correlates of P300 in Drug-naïve Patients with Schizophrenia
- 運動對思覺失調症患者認知表現之文獻回顧
頁籤選單縮合
題名 | Does Biofeedback Improve Symptoms of Schizophrenia (Emotion, Psychotic Symptoms, and Cognitive Function)?=生理回饋可以治療思覺失調症病人之症狀(情緒、精神症狀及認知功能)嗎? |
---|---|
作 者 | 林家如; 洪一永; 林敬淳; 蔡孟璋; 黃條來; | 書刊名 | Taiwanese Journal of Psychiatry |
卷期 | 30:2 2016.06[民105.06] |
頁次 | 頁120-127+a8 |
分類號 | 415.983 |
關鍵詞 | 生理回饋; 認知功能; 情緒; 思覺失調症; Biofeedback; Cognitive function; Emotion; Schizophrenia; |
語文 | 英文(English) |
中文摘要 | 背景:評估生理回饋治療對於改善思覺失調病人的情緒、精神症狀及認知功能的效果。方法:自2012 年至2013 年,共25 位診斷為思覺失調症病人被招募,包括生理回饋組16 位(漸進式肌肉放鬆的個別治療,每週3 次,持續兩週)和控制組9 位。所有病人均接受貝克憂鬱量表- 第二版 (BDI-II)、貝克焦慮量表 (BAI)、症狀檢核量表 (SCL-90R) 和路徑描繪測驗(Trial Making Test, TMT)。結果:結果顯示治療組在BAI (p = 0.05),SCL-90R 中的depression(p = 0.05),anxiety (p = 0.05),paranoid ideation (p < 0.05),additional items(睡眠障礙與食慾問題)(p < 0.05) 指標均有顯著降低,認知功能部分,TMT A (p = 0.01) 也有顯著降低。對照組則是在TMT A (p = 0.01) 及TMT B (p = 0.01) 均有顯著下降。顯示在兩組間,認知功能沒有顯著差異的改善。結論:生理回饋可以改善思覺失調症病人的憂鬱,焦慮,妄想,睡眠障礙和食慾等臨床症狀。 |
英文摘要 | Objectives: Patients with schizophrenia tend to experience emotional distressand to have impaired cognitive function. The objective of this study was to investigatethe effect of the biofeedback therapy on patients with schizophrenia. Methods: From December 1, 2012 to November 30, 2013, we recruited in- and outpatientsdiagnosed with schizophrenia. They were randomized into the biofeedbackgroup (treated with individual progressive muscle relaxation therapy [PMRT], three times a week, for two weeks) and the control group. All patients were evaluatedusing Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), Symptom Checklist-90-R, and Trial Making Test (TMT). Results: We recruited 25patients, including 16 in the biofeedback group and 9 in the control group. Theresults showed significantly lower BAI scores (p = 0.05), lower depression (p =0.05), lower anxiety (p = 0.05), lower paranoid ideation (p < 0.05), lower additionalitems (sleep disturbances and appetite) (p < 0.05) and lower TMT A (p =0.01) scores in the biofeedback group compared to the control group. TMT A (p =0.01) and TMT B (p = 0.01) were found to be significantly lower in the controlgroup. No statistical significance was found in the cognitive function improvementbetween the two groups. Conclusion: Biofeedback could improve the clinicalsymptoms of depression, anxiety, paranoid ideation, sleep disturbances and appetitein patients with schizophrenia. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。